Capsule Endoscopy in Inflammatory Bowel Disease (IBD) in Children

Sponsored by Children's Mercy Hospital Kansas City

Phase Quota
Phase N/A

Most of the studies evaluating the roles of MRE and WCE conducted in pediatric patients have been retrospective with the main goal of making a diagnosis in patients with suspected IBD. The current study is the first prospective study in children with known IBD assessing the roles of MRE and WCE in identifying disease exacerbation. This study will help to identify if capsule endoscopy is superior or complementary to MRE in the evaluation of suspected disease exacerbation in IBD patients.

Study Start Date: January 2014

Estimated Completion Date: January 2016

Specialties: Gastroenterology: Endoscopy,Peds Gastroenterology,Small/Large Intestine Physician Assistant: Gastroenterology,Pediatrics


  • Device: Capsule endoscopy

Inclusion criteria

  • Patients aged 4 to 17.99 years at time of investigation
  • IBD/CD and IBD/IC diagnosed based on standard clinical - histologic criteria
  • Patient is scheduled to have MRE as standard of care for evaluation of disease severity/ complication
  • Signed permission/assent/consent

Exclusion criteria

  • IBD diagnosis not established
  • Recent intestinal tract surgery / resection involving small bowel
  • Use of NSAIDs 4 weeks prior to the Capsule endoscopy study
  • Patients are on prokinetic medication
  • Swallowing disorders, esophageal stricture or patients unable to swallow the capsule
  • Presence of gastrointestinal obstruction or ileus
  • Patient with implanted electro-medical device or pacemakers.

Study Locations And Contact Information

  • Children Mercy Hospital and Clinics, Kansas City Kansas
    Contact: Shawna Ricks RN 816-234-3197

Feature this Clinical Trial

Get your trial in front of 1000s of physicians and patients.
Visit to find out how you can feature this clinical trial.